Video

Taking a Closer Look at PCSK9

Author(s):

One of the hot topics at the American College of Cardiology's annual meeting in San Diego was a new class of drugs being developed that could revolutionize the field of cardiac care.

One of the hot topics at the American College of Cardiology's annual meeting in San Diego was a new class of drugs being developed that could revolutionize the field of cardiac care.

Jennifer Robinson, MD, MPH, from the University of Iowa discussed this latest development while presenting two paper on the topic at the event.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.